Yellow Fever Vaccine

Sayenna Uduman
Spectrum of Clinical Illness
Clinical presentation varies in severity from asymptomatic to fatal. When symptomatic, YF is typically characterized by an acute onset of an undifferentiating febrile flu-like illness. In about 85% of cases, the disease resolves when the acute symptoms subside. For others, after a brief remission lasting anywhere between hours to a day, symptoms worsen and the disease advances, eventually leading to renal failure, hemorrhagic symptoms, and thrombocytopenia. Treatment is symptomatic and supportive. The WHO estimates, an estimated 200,000 people become infected each year, with up to 30,000 deaths annually. Older adults and those with compromised immune systems are most at risk for serious complications.

This depends upon various factors that would include: immunization status, use of personal protection measures against mosquito bites, travel history & location, duration of exposure, local rate of virus transmission and activities while travelling. The risk for acquiring YF is low for most travelers, particularly those staying in highly developed major urban areas.

Yellow Fever Vaccine Yellow Fever Vaccine 04/13/2016
<< Key Information Vaccine Preventable Disease >>
ask a doctor
Ask a Doctor
Disclaimer: The information given by is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0